- Home
- ALZN vs IMTE Comparison
ALZN vs IMTE Comparison
Compare ALZN & IMTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- IMTE
- Stock Information
- Founded
- ALZN 2016
- IMTE 2008
- Country
- ALZN United States
- IMTE Malaysia
- Employees
- ALZN N/A
- IMTE N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- IMTE Consumer Electronics/Appliances
- Sector
- ALZN Health Care
- IMTE Consumer Staples
- Exchange
- ALZN Nasdaq
- IMTE Nasdaq
- Market Cap
- ALZN 6.1M
- IMTE 5.3M
- IPO Year
- ALZN 2021
- IMTE N/A
- Fundamental
- Price
- ALZN $0.96
- IMTE $1.26
- Analyst Decision
- ALZN Strong Buy
- IMTE
- Analyst Count
- ALZN 1
- IMTE 0
- Target Price
- ALZN $32.00
- IMTE N/A
- AVG Volume (30 Days)
- ALZN 825.5K
- IMTE 6.4K
- Earning Date
- ALZN 03-24-2025
- IMTE 03-04-2025
- Dividend Yield
- ALZN N/A
- IMTE N/A
- EPS Growth
- ALZN N/A
- IMTE N/A
- EPS
- ALZN N/A
- IMTE N/A
- Revenue
- ALZN N/A
- IMTE $123,337.00
- Revenue This Year
- ALZN N/A
- IMTE N/A
- Revenue Next Year
- ALZN N/A
- IMTE N/A
- P/E Ratio
- ALZN N/A
- IMTE N/A
- Revenue Growth
- ALZN N/A
- IMTE 4.75
- 52 Week Low
- ALZN $0.92
- IMTE $1.06
- 52 Week High
- ALZN $15.06
- IMTE $3.84
- Technical
- Relative Strength Index (RSI)
- ALZN 26.54
- IMTE 47.80
- Support Level
- ALZN $0.92
- IMTE $1.21
- Resistance Level
- ALZN $1.15
- IMTE $1.30
- Average True Range (ATR)
- ALZN 0.06
- IMTE 0.07
- MACD
- ALZN -0.01
- IMTE -0.00
- Stochastic Oscillator
- ALZN 13.61
- IMTE 30.16
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.